DreamCIS, Inc. (KOSDAQ:223250)

South Korea · Delayed Price · Currency is KRW

5,150.00

-180.00 (-3.38%)

At close: Mar 12, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Consolidation Adjustment	-2.78B	-1.72B	-576.65M	-	-
Clinical Trial Human Resources Support Department	1.09B	-	-	-	-
Medical Consulting	15.05B	15.14B	7.25B	-	-
Medical Consulting Growth	-0.60%	108.86%	-	-	-
Clinical Trial Management Agency	45.28B	34.42B	32.20B	-	23.49B
Clinical Trial Management Agency Growth	31.55%	6.90%	-	-	6.24%
Total	58.65B	47.84B	38.87B	-	23.49B
Total Growth	22.59%	23.08%	-	-	6.24%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea	52.51B	43.36B	34.24B	23.24B	20.50B
South Korea Growth	21.11%	26.62%	47.34%	13.38%	9.71%
Overseas	6.14B	4.49B	4.63B	2.91B	2.99B
Overseas Growth	36.92%	-3.11%	58.96%	-2.63%	-12.65%
Total	58.65B	47.84B	38.87B	26.15B	23.49B
Total Growth	22.59%	23.08%	48.64%	11.34%	6.24%

Source: S&P Global Market Intelligence.